Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverly Nickerson

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
International Journal of Clinical Pharmacology and Therapeutics|May 16, 2022
Relative bioavailability of ertugliflozin tablets containing the amorphous form versus tablets containing the cocrystal formVaishali Sahasrabudhe, Kyle Matschke, Haihong Shi, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 19, 2008
Leveraging elevated temperature and particle size reduction to extract API from various tablet formulationsBeverly Nickerson, William B Arikpo, Mark R Berry, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 22, 2004
Identification of low-level degradants from low dose tabletsAndrew Blanchard, Carlos Lee, Beverly Nickerson, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
International Journal of Clinical Pharmacology and Therapeutics|May 16, 2022
Relative bioavailability of ertugliflozin tablets containing the amorphous form versus tablets containing the cocrystal formVaishali Sahasrabudhe, Kyle Matschke, Haihong Shi, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 19, 2008
Leveraging elevated temperature and particle size reduction to extract API from various tablet formulationsBeverly Nickerson, William B Arikpo, Mark R Berry, et al.
Journal of Pharmaceutical and Biomedical Analysis|October 22, 2004
Identification of low-level degradants from low dose tabletsAndrew Blanchard, Carlos Lee, Beverly Nickerson, et al.
Pageof 2